| scholarly article | Q13442814 |
| P2093 | author name string | R T Chung | |
| K E Sherman | |||
| L Hua | |||
| N Kemmer | |||
| J W Andersen | |||
| A A Butt | |||
| ACTG 5178 Study Team | |||
| P2860 | cites work | Prolonged Therapy of Advanced Chronic Hepatitis C with Low-Dose Peginterferon | Q27487518 |
| Health-related quality of life of patients with HIV disease: impact of hepatitis C coinfection | Q31041310 | ||
| The effects of interferon alpha-2b in combination with ribavirin on health related quality of life and work productivity | Q32043227 | ||
| Type and etiology of liver cirrhosis are not related to the presence of hepatic encephalopathy or health-related quality of life: a cross-sectional study | Q33376874 | ||
| Outcomes research in chronic viral hepatitis C: effects of interferon therapy | Q33999954 | ||
| Changes in quality of life and sexual health are associated with low-dose peginterferon therapy and disease progression in patients with chronic hepatitis C. | Q34072683 | ||
| Development and validation of a self-completed HIV symptom index. | Q34466580 | ||
| Sustained long-term antiviral maintenance therapy in HCV/HIV-coinfected patients (SLAM-C) | Q34474434 | ||
| Clinical importance of HIV and depressive symptoms among veterans with HIV infection | Q34743154 | ||
| Screening for depression in well older adults: evaluation of a short form of the CES-D (Center for Epidemiologic Studies Depression Scale) | Q39513295 | ||
| Hepatitis C virus infection affects the brain-evidence from psychometric studies and magnetic resonance spectroscopy | Q42172153 | ||
| Cognitive function, mood and health-related quality of life in hepatitis C virus (HCV)-monoinfected and HIV/HCV-coinfected individuals commencing HCV treatment. | Q43037428 | ||
| Prevalence and significance of neurocognitive dysfunction in hepatitis C in the absence of correlated risk factors. | Q44906505 | ||
| Impact of indinavir on the quality of life in patients with advanced HIV infection treated with zidovudine and lamivudine | Q45015450 | ||
| Neuropsychological test performance in patients co-infected with hepatitis C virus and HIV. | Q45423059 | ||
| The neuropsychological and neurological impact of hepatitis C virus co-infection in HIV-infected subjects | Q45423061 | ||
| The impact of peginterferon alfa-2a plus ribavirin combination therapy on health-related quality of life in chronic hepatitis C. | Q46161384 | ||
| Evidence for neuroinflammation and neuroprotection in HCV infection-associated encephalopathy | Q46225098 | ||
| Influence of hepatic encephalopathy on health-related quality of life in patients with cirrhosis | Q47682942 | ||
| Reduction of health-related quality of life in chronic hepatitis C and improvement with interferon therapy. The Consensus Interferon Study Group. | Q50851322 | ||
| Health-related quality of life in patients with different stages of liver disease induced by hepatitis C. | Q51869405 | ||
| Mental status impairment in patients with West Haven grade zero hepatic encephalopathy: the role of HCV infection. | Q51906595 | ||
| Impact of chronic viral hepatitis on health-related quality of life in HIV: results from a nationally representative sample. | Q51926482 | ||
| Peginterferon alpha-2a (40kD) [Pegasys] improves HR-QOL outcomes compared with unmodified interferon alpha-2a [Roferon-A]: in patients with chronic hepatitis C. | Q53394448 | ||
| Derivation and properties of a brief health status assessment instrument for use in HIV disease | Q72553132 | ||
| Human immunodeficiency virus and liver disease: conference proceedings | Q82364583 | ||
| P433 | issue | 11 | |
| P304 | page(s) | 792-800 | |
| P577 | publication date | 2012-04-22 | |
| P1433 | published in | Journal of Viral Hepatitis | Q15749962 |
| P1476 | title | Health-related quality of life in subjects with HCV/HIV coinfection: results from ACTG 5178 study | |
| P478 | volume | 19 |
| Q39093985 | Depression in HIV and HCV co-infected patients: a systematic review and meta-analysis |
| Q42281169 | Health-related quality of life and severity of fatigue in HIV/HCV co-infected patients before, during, and after antiviral therapy with pegylated interferon plus ribavirin |
| Q57292019 | Impact of successful treatment with direct-acting antiviral agents on health-related quality of life in chronic hepatitis C patients |
| Q57022320 | Mechanisms of neuropathogenesis in HIV and HCV: similarities, differences, and unknowns |
| Q39002714 | Patient-reported outcomes with direct-acting antivirals for the treatment of chronic hepatitis C: current knowledge and outstanding issues |
| Q35124931 | Quality of life assessment among HIV-positive persons entering the INSIGHT Strategic Timing of AntiRetroviral Treatment (START) trial |
| Q41460664 | Spontaneous and post-treatment HCV clearance: relationships with health-related quality of life in HIV infection (ANRS-VESPA2 study). |
| Q38153794 | Use of first-generation HCV protease inhibitors in patients coinfected by HIV and HCV genotype 1. |
| Q38192047 | Using patient-reported outcomes to improve the management of co-infection with HIV and HCV: the ANRS CO13 HEPAVIH cohort |
Search more.